Biosynthesis Peptide Drugs Market Size, Trends and Companies 2026-2035
The global biosynthesis peptide drugs market size was $18.31B in 2024 and is expected to grow at a 6.26% CAGR during 2025-2034. The market is predicted to reach $32.88B by 2034. The market growth is driven by the rise in GLP-1 receptor agonists, innovative synthesis technologies, use of PDCs in oncology, rise in ral peptide solutions, increased pharmaceutical investments, rise in custom medicines, and the expansion of automated peptide synthesizers. Payal Rabde, senior research analyst, has analyzed this market based on regional growth drivers, segmental analysis, key trends, and recent advancements. Her research is useful for healthcare providers, investors, medical product developers, and biotechnology firms for decision-making and competitive benchmarking.
Last Updated : 12 October 2026
Category: Therapeutic Area
Insight Code: 6354
Format: PDF / PPT / Excel